Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
22 hedge funds and large institutions have $3.04M invested in Orgenesis Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
27% more capital invested
Capital invested by funds: $2.4M → $3.04M (+$640K)
10% more funds holding
Funds holding: 20 → 22 (+2)
0.32% more ownership
Funds ownership: 7.41% → 7.73% (+0.32%)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RAM
Redmond Asset Management
Henrico,
Virginia
|
+$142K |
| 2 |
Walleye Capital
New York
|
+$84.4K |
| 3 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
+$14.8K |
| 4 |
BlackRock
New York
|
+$12.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$403 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Prudential Financial
Newark,
New Jersey
|
-$32.5K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$23.9K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$12.6K |
| 4 |
JP Morgan Chase
New York
|
-$2.41K |
| 5 |
Renaissance Technologies
New York
|
-$356 |
ORGS Hedge Fund Activity: Q2 2023 in Review
22 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q2 2023, worth a combined $3.04M — up 27% from $2.4M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ORGS positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 5 trimmed.
The largest buyer was Redmond Asset Management, adding an estimated $142K. The largest seller was Prudential Financial, exiting entirely with an estimated $32.5K sold.
- 22 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q2 2023, up from 20 in Q1 2023.
- Funds reported $3.04M of Orgenesis Inc. Common Stock stock for Q2 2023, up 27% quarter-over-quarter.
- 3 funds opened new Orgenesis Inc. Common Stock positions in Q2 2023 and 1 closed out, a net change of +2 holders.
- The largest Orgenesis Inc. Common Stock buyer in Q2 2023 was Redmond Asset Management, an estimated $142K added.
- The largest Orgenesis Inc. Common Stock seller in Q2 2023 was Prudential Financial, an estimated $32.5K sold.
Based on aggregated 13F filings for Q2 2023.